Arbitrator Voids Beckman’s Sale of HPV IP to Ventana;
Beckman Says Business Not Impacted
 
An arbitration panel has ruled that Beckman Coulter violated the terms of an original cross-license agreement between Institut Pasteur and Digene when it sold its human papillomavirus intellectual property to Ventana, Digene announced this week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.